Home -> Law Blog Directory -> Patent Law Blogs -> IPBiz
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: IPBizForgetting the patent grant rate debate?
By Lawrence B. Ebert, Esq.
Patents, Nanotechnology and the US Patent Office
See also Statistical Musings which managed to ignore all past discussion of the patent grant rate debate.
HOWEVER, see text in Bronzino's Tissue Engineering, which cites to "Things are not always what they seem to be," which appeared in IPT two years BEFORE Statistical Musings. [See also IPT, Aug. 2007]
Ironically, even after the failings of the Quillen and Webster assertion are forgotten, the Quillen/Webster legacy lives on in the form of the "patent quality" debate. And some people still cite the work of Jan-Hendrik Schon.
Full post as published by IPBiz on February 12, 2008 (boomark / email).
Truth In Lending Act
Consumer Loans and Consumer Credit Protection Act
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.
Auction Rate Securities
ARS stocks purchased from a brokerage
Nail Guns
Injury Rate More Than Doubles in Three Years
JP Morgan Chase & Co
Faces Lawsuit Over Hikes in Credit Card Interest Rate

Federal Circuit Patent Mediation Success Rate at 42%
Presidential "Debate" on U.S. Patent Policy
Patent Office on Patent Reform
As Approval Rate for U.S. Patents Drops, Applicant Shift to Appeals
USPTO Statistics: Fewer Allowances, More Appeals









